Currently, breast cancer is classified based on the proliferation index (Ki67) and expression of hormone receptors, namely estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). This evidence concerns the gene MKI67 and breast carcinoma.